INTERIM RESULTS FROM THE OCRIPLASMIN FOR VITREOMACULAR TRACTION INTRAVITREAL INJECTION DECISIONS (OVIID-I) TRIAL

被引：0
|
作者：
Chang, Andrew [1 ,2 ]
机构：
[1] Sydney Eye Hosp, Sydney, NSW, Australia
[2] Sydney Retina Clin & Day Surg, Sydney, NSW, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2015年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] Skin and needle hygiene intervention for injection drug users: Results from a randomized, controlled Stage I pilot trial
    Phillips, Kristina T.
    Stein, Michael D.
    Anderson, Bradley J.
    Corsi, Karen F.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2012, 43 (03) : 313 - 321
  • [32] Interim results from a phase I trial of SL-801: A novel XPO-1 inhibitor, in patients with advanced solid tumors
    Bauer, T. M.
    Barve, M.
    Chiorean, E. G.
    Lorusso, P.
    Courtney, K.
    Qi, D.
    Olguin, A.
    Bullington, J.
    Sardone, M.
    Dunn, V.
    Shemesh, S.
    Chen, J.
    Brooks, C.
    Wang, J.
    ANNALS OF ONCOLOGY, 2018, 29 : 140 - 140
  • [33] Interim Results from a Phase I/II Trial of Nivolumab in Combination with CIMAvax-EGF as Second-Line Therapy in Advanced NSCLC
    Dy, G.
    Dozier, A.
    Reid, M.
    Lee, K.
    Miller, A.
    Wallace, P.
    Puzanov, I.
    Opyrchal, M.
    Ernstoff, M.
    Johnson, C.
    Mazorra, Z.
    Saavedra, D.
    Leon, K.
    Lage, A.
    Crombet, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S740 - S740
  • [34] Interim results from a phase I/II trial of TPI 287, a novel brain penetrable antimicrotubule agent, in combination with bevacizumab for the treatment of recurrent glioblastoma
    Silberman, Sandra L.
    Goldlust, Samuel
    Nabors, L. Burt
    Duic, J. Paul
    Benkers, Tara
    Mohile, Nimish
    Picker, Donald
    Singer, Samuel
    Farmer, George
    CANCER RESEARCH, 2015, 75
  • [35] Intravitreal aflibercept 8 mg injection in patients with neovascular age-related macular degeneration: 48-week results from the Phase 3 PULSAR trial
    Spitzer, Martin Stephan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [36] INTERIM RESULTS FROM A PHASE I CLINICAL TRIAL OF THE BCR-ABL INHIBITOR XL228 IN DRUG-RESISTANT PH+ LEUKEMIAS
    Shah, P.
    Asatiani, E.
    Cortes, J.
    Paquette, R. L.
    Pinilla-Ibarz, J.
    Kasap, C.
    Bui, L. A.
    Yaron, Y.
    Clary, D. O.
    Talpaz, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 47 - 48
  • [37] Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial
    Welsh, James W.
    Seyedin, Steven N.
    Allen, Pamela K.
    Hofstetter, Wayne L.
    Ajani, Jaffer A.
    Chang, Joe Y.
    Gomez, Daniel R.
    Amini, Arya
    Swisher, Stephen G.
    Blum, Mariela A.
    Younes, Ahmed I.
    Quynh-Nhu Nguyen
    Minsky, Bruce D.
    Erasmus, Jeremy J.
    Lee, Jeffrey H.
    Bhutani, Manoop
    Komaki, Ritsuko U.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 375 - 382
  • [38] Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome
    Mazzini, Letizia
    Gelati, Maurizio
    Profico, Daniela Celeste
    Soraru, Gianni
    Ferrari, Daniela
    Copetti, Massimiliano
    Muzi, Gianmarco
    Ricciolini, Claudia
    Carletti, Sandro
    Giorgi, Cesare
    Spera, Cristina
    Frondizi, Domenico
    Masiero, Stefano
    Stecco, Alessandro
    Cisari, Carlo
    Bersano, Enrica
    De Marchi, Fabiola
    Sarnelli, Maria Francesca
    Querin, Giorgia
    Cantello, Roberto
    Petruzzelli, Francesco
    Maglione, Annamaria
    Zalfa, Cristina
    Binda, Elena
    Visioli, Alberto
    Trombetta, Domenico
    Torres, Barbara
    Bernardini, Laura
    Gaiani, Alessandra
    Massara, Maurilio
    Paolucci, Silvia
    Boulis, Nicholas M.
    Vescovi, Angelo L.
    STEM CELLS TRANSLATIONAL MEDICINE, 2019, 8 (09) : 887 - 897
  • [39] Intracerebroventricular Radioimmunotherapy Using 131I-Omburtamab for Neuroblastoma Central Nervous System/Leptomeningeal Metastases, Interim Results From Multi-Center Trial 101
    Lisby, S.
    Kramer, K.
    Vik, T.
    Streby, K.
    Hyseni, A.
    Mora, J.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S49 - S50
  • [40] Intravitreal Aflibercept 8mg Injection in patients with neovascular age-related macular degeneration: 60+96 week results from the Phase 3 Pulsar trial
    Chang, Andrew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 933 - 933
12345